Skip to content

The team Our story The project Media Guestbook
Our technology Autoimmune diseases Myasthenia gravis Publications
Pipeline Veterinary Unit
Investment Donations
News
Contact

Donate Investment

Company

The team Our story The project Media Guestbook

Science

Our technology Autoimmune diseases Myasthenia gravis Publications

Development

Pipeline Veterinary Unit

Funding

Investment Donations

News Contact

FR NL EN ES DE

Home / Media / Targeted Active Therapy explained

Targeted Active Therapy explained

The mechanism of TAT, explained simply.

For a world free of autoimmune diseases. A Belgian clinical-stage biotech.

Company

The team
Our story
The project
Media
News

Science

Our technology
Autoimmune diseases
Myasthenia gravis
Publications

Development

Pipeline
Veterinary Unit

Funding

Investment
Donate

Contact

Rixensart, Belgium
info@curavac.com
Contact us

Stay informed

Get our news and progress, straight to your inbox.

Website

I agree to receive CuraVac's newsletter. You can unsubscribe at any time.

© 2026 CuraVac Europe S.A.

Privacy policy · Manage cookies | EN·FR·NL·ES·DE

Be the first to know when our investment campaign goes live

Notify me